Continued treatment with secukinumab is associated with high retention or regain of response.
Augustin M, Thaci D, Eyerich K, Pinter A, Radtke M, Lauffer F, Mrowietz U, Gerdes S, Pariser D, Lebwohl M, Sieder C, Melzer N, Reich K.
Augustin M, et al. Among authors: pinter a.
Br J Dermatol. 2020 Jan;182(1):67-75. doi: 10.1111/bjd.17991. Epub 2019 Jul 17.
Br J Dermatol. 2020.
PMID: 30972746